Skip to main content
Equibles

FRED ALGER MANAGEMENT, LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 3520 NEW YORK, NY
Back to ROIV Full portfolio

Position in ROIV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$38,271,489
+$12,643,837 QoQ
Shares Held
1,081,421
+16.9% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRED ALGER MANAGEMENT, LLC holds $805,760,903 across 54 Biotechnology names. ROIV ranks #7 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARWR
Arrowhead Pharmaceuticals, Inc.
 3,301,919 $269,139,417
2 DNTH
Dianthus Therapeutics, Inc. /DE/
 1,302,493 $126,967,017
3 TWST
Twist Bioscience Corp
 558,157 $57,423,192
4 RVMD
Revolution Medicines, Inc.
 259,468 $48,593,167
5 ASND
Ascendis Pharma A/S
 171,447 $45,728,343
6 COGT
Cogent Biosciences, Inc.
 1,072,830 $41,518,521
7 ROIV
Roivant Sciences Ltd.
This page 		1,081,421 $38,271,489
8
1,439,697 $30,593,561

All Filings in ROIV

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,271,489 1,081,421
2026-03-31 $25,627,652 925,186
2025-12-31 $2,427,622 111,872